Aclaris Therapeutics 发布了2026年第二季度的财务报告,同时就公司运营与临床开发的最新动态进行了通报。
Aclaris Therapeutics 发布了2026年第二季度的财务报告,同时就公司运营与临床开发的最新动态进行了通报。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.